Since malaria guidelines in Brazil had been updated to require G6PD screening before primaquine at health facilities that have the capacity to perform G6PD tests, a second comparison evaluated tafenoquine following semi-quantitative G6PD screening compared to primaquine following semi-quantitative G6PD screening. The gene discussed is G6PD; the disease is malaria.